相似文献
1
Evaluation of novel '-(3-hydroxybenzoyl)-2-oxo-2-chromene-3-carbohydrazide derivatives as potential HIV-1 integrase inhibitors.
Medchemcomm. 2018 Dec 10;10(1):80-88. doi: 10.1039/c8md00328a. eCollection 2019 Jan 1.
2
Design, Synthesis, Molecular Modeling Study and Biological Evaluation of New N'-Arylidene-pyrido [2,3-]pyrimidine-5-carbohydrazide Derivatives as Anti-HIV-1 Agents.
Iran J Pharm Res. 2019 Fall;18(Suppl1):237-248. doi: 10.22037/ijpr.2019.112198.13597.
3
Design, Synthesis, Docking Study, and Biological Evaluation of 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbohydrazide Derivatives as Anti-HIV-1 and Antibacterial Agents.
Iran J Pharm Res. 2022 May 4;21(1):e126562. doi: 10.5812/ijpr-126562. eCollection 2022 Dec.
4
Synthesis, Biological Evaluation, and Molecular Modeling Studies of New 8-methyl-4-oxo-1,4-dihydroquinoline-3-carbohydrazides as Potential Anti-HIV Agents.
Iran J Pharm Res. 2022 May 17;21(1):e123962. doi: 10.5812/ijpr-123962. eCollection 2022 Dec.
5
Design, Synthesis, Molecular Modeling Studies and Biological Evaluation of N'-Arylidene-6-(benzyloxy)-4-oxo-1,4-dihydroquinoline-3-carbohydrazide Derivatives as Novel Anti-HCV Agents.
Iran J Pharm Res. 2019 Fall;18(4):1790-1802. doi: 10.22037/ijpr.2019.112186.13586.
6
Synthesis and kinetics studies of N'-(2-(3,5-disubstituted-4H-1,2,4-triazol-4-yl)acetyl)-6/7/8-substituted-2-oxo-2H-chromen-3-carbohydrazide derivatives as potent antidiabetic agents.
Arch Pharm (Weinheim). 2019 Dec;352(12):e1900227. doi: 10.1002/ardp.201900227. Epub 2019 Oct 14.
7
Novel 4-Oxo-4,10-dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylic Acid Derivatives as HIV-1 Integrase Inhibitors: Synthesis, Docking Studies, Molecular Dynamics Simulation and Biological Activities.
Med Chem. 2021;17(9):1060-1071. doi: 10.2174/1573406416666200909104616.
8
Erratum: Crystal structures and Hirshfeld surface analyses of ()-'-benzyl-idene-2-oxo-2-chromene-3-carbo-hydrazide and the disordered hemi-DMSO solvate of ()-2-oxo-'-(3,4,5-trimeth-oxybenzyl-idene)-2-chromene-3-carbohydrazide: lattice energy and inter-molecular inter-action energy calculations for the former. Corrigendum.
Acta Crystallogr E Crystallogr Commun. 2019 Nov 29;75(Pt 12):1952. doi: 10.1107/S2056989019014890. eCollection 2019 Dec 1.
9
A New Fluorescent "Turn-Off" Coumarin-Based Chemosensor: Synthesis, Structure and Cu-Selective Fluorescent Sensing in Water Samples.
J Fluoresc. 2017 Jul;27(4):1293-1298. doi: 10.1007/s10895-017-2062-x. Epub 2017 Mar 10.
10
A facile synthesis of novel biologically active 4-hydroxy-N'-(benzylidene)-2H-benzo[e][1,2]thiazine-3-carbohydrazide 1,1-dioxides.
Eur J Med Chem. 2009 Mar;44(3):1311-6. doi: 10.1016/j.ejmech.2008.08.002. Epub 2008 Aug 13.
引用本文的文献
1
Regulation of adipocyte differentiation and lipid metabolism by novel synthetic chromenes exploring anti-obesity and broader therapeutic potential.
Sci Rep. 2025 Feb 3;15(1):4051. doi: 10.1038/s41598-025-87945-1.
2
Recent Progress in Synthesis, POM Analyses and SAR of Coumarin-Hybrids as Potential Anti-HIV Agents-A Mini Review.
Pharmaceuticals (Basel). 2023 Oct 31;16(11):1538. doi: 10.3390/ph16111538.
3
Synthesis of novel coumarin-hydrazone hybrids as α-glucosidase inhibitors and their molecular docking studies.
RSC Adv. 2023 Sep 4;13(37):26229-26238. doi: 10.1039/d3ra03953f. eCollection 2023 Aug 29.
4
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study.
Int J Mol Sci. 2023 Jan 11;24(2):1425. doi: 10.3390/ijms24021425.
5
Chromenol Derivatives as Novel Antifungal Agents: Synthesis, In Silico and In Vitro Evaluation.
Molecules. 2021 Jul 16;26(14):4304. doi: 10.3390/molecules26144304.
6
Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease.
Front Chem. 2021 Feb 8;8:595097. doi: 10.3389/fchem.2020.595097. eCollection 2020.
7
An Overview of Coumarin as a Versatile and Readily Accessible Scaffold with Broad-Ranging Biological Activities.
Int J Mol Sci. 2020 Jun 29;21(13):4618. doi: 10.3390/ijms21134618.
8
Coumarin: An emerging antiviral agent.
Heliyon. 2020 Jan 27;6(1):e03217. doi: 10.1016/j.heliyon.2020.e03217. eCollection 2020 Jan.
本文引用的文献
1
Adult antiretroviral therapy guidelines 2017.
South Afr J HIV Med. 2017 Jul 15;18(1):776. doi: 10.4102/sajhivmed.v18i1.776. eCollection 2017.
2
Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile.
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7086-7097. doi: 10.1128/AAC.01474-16. Print 2016 Dec.
3
Targeting HIV-1 integrase with strand transfer inhibitors.
Drug Discov Today. 2015 Apr;20(4):435-49. doi: 10.1016/j.drudis.2014.12.001. Epub 2014 Dec 6.
4
HIV-1 integrase inhibitors: a review of their chemical development.
Antivir Chem Chemother. 2011 Nov 17;22(3):95-105. doi: 10.3851/IMP1740.
5
Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups.
Bioorg Med Chem. 2011 Aug 15;19(16):4935-52. doi: 10.1016/j.bmc.2011.06.058. Epub 2011 Jun 26.
6
Synthesis of a novel hydrazone derivative and biophysical studies of its interactions with bovine serum albumin by spectroscopic, electrochemical, and molecular docking methods.
J Phys Chem B. 2010 Nov 25;114(46):14842-53. doi: 10.1021/jp105766n. Epub 2010 Nov 1.
7
A dynamic model of HIV integrase inhibition and drug resistance.
J Mol Biol. 2010 Mar 26;397(2):600-15. doi: 10.1016/j.jmb.2010.01.033. Epub 2010 Jan 22.
8
Strand transfer inhibitors of HIV-1 integrase: bringing IN a new era of antiretroviral therapy.
Antiviral Res. 2010 Jan;85(1):101-18. doi: 10.1016/j.antiviral.2009.11.004. Epub 2009 Nov 17.
9
Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go?
J Med Chem. 2010 Jan 28;53(2):521-38. doi: 10.1021/jm900492g.
10
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
J Comput Chem. 2010 Jan 30;31(2):455-61. doi: 10.1002/jcc.21334.
Zotero 插件